CBS-3595

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCBS-3595
Drug Alias NameCBS-3595ML-3595
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitorsPhosphodieterase 4 inhibitors
TargetsP38 mitogen-activated protein kinasePhosphodieterase 4
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerckle Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesC-A-I-R BiosciencesMerckle Gmbh
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A